Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Acetonide in Nail Psoriasis
NCT03991936Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2020
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in nail psoriasis, sponsored by Weill Cornell Medicine. Started Mar 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on NCT03991936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03991936.